Novartis Champions Cosentyx With More Long-Term Psoriasis Data

PS1711_Trumpet Player_196485695_1200
Novartis has been trumpeting the long-term efficacy of Cosentyx for psoriasis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Immunological

More from Therapeutic Category